Letter to the editor: the inflamed subclass predicts immunotherapy response - external validations

Gut. 2022 Jul 16:gutjnl-2022-328130. doi: 10.1136/gutjnl-2022-328130. Online ahead of print.

Authors

Binghua Li¹, Yajuan Cao¹, Yunzheng Li¹, Chunxiao Cheng², Decai Yu^{3

2}

Affiliations

¹ Department of Hepatobiliary Surgery, the Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
² Department of Hepatobiliary Surgery, the Affiliated Drum Tower Hospital, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
³ Department of Hepatobiliary Surgery, the Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China yudecai@nju.edu.cn.

PMID: 35842234
DOI: 10.1136/gutjnl-2022-328130

No abstract available

Keywords: HEPATOCELLULAR CARCINOMA; IMMUNOTHERAPY.

Publication types

Letter